Global Athlete's Foot Drugs Market
Global Athlete's Foot Drugs Market

Athlete's Foot Drugs Comprehensive Study by Type (OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate), Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-user (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2026

Athlete's Foot Drugs Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 236 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Athlete's Foot Drugs Market?

Athlete’s foot, also known as tinea pedi or ringworm, of the foot is a fungal infection that affects the upper layer of the skin of the foot, especially when it is warm, moist, and irritated. This infection commonly occurs in people whose feet have become very sweaty while confined within tight-fitting shoes. The symptoms of an Athlete’s foot involve itching, stinging and burning. It is treated with over the counter drugs and prescription medications

The market study is being classified by Type (OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate) and Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)) and major geographies with country level break-up.

Mylan N.V. (United States), Novartis International AG (Switzerland), Pfizer Inc. (United States), Merck & Co., Inc. (United States), Sanofi S.A. (France), Bayer AG (Germany), Enzon Pharmaceuticals, Inc. (United States), GlaxoSmithKline plc (United Kingdom), Abbott Laboratories (United States) and Teva Pharmaceutical Industries Ltd. (Israel) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Athlete's Foot Drugs market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Athlete's Foot Drugs market by Type, Application and Region.

On the basis of geography, the market of Athlete's Foot Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Fungal Infections among People
  • Rise in the Number of Hospitals and Diagnostic Centres
  • Easy Availability of the OTC (over-the-counter) Medications

Market Trend
  • Increased Number of Online Pharmacies

Restraints
  • Less Awareness about Athlete's Foot Treatment

Opportunities
  • Increased Research and Development Activities
  • Growth in the Healthcare Industry Worldwide

Challenges
  • Stringent Government Rules and Regulations





Key Target Audience
Athlete's Foot Drugs Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate)
  • Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By End-user
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Fungal Infections among People
      • 3.2.2. Rise in the Number of Hospitals and Diagnostic Centres
      • 3.2.3. Easy Availability of the OTC (over-the-counter) Medications
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Number of Online Pharmacies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Athlete's Foot Drugs, by Type, Distribution Channel, End-user and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Athlete's Foot Drugs (Value)
      • 5.2.1. Global Athlete's Foot Drugs by: Type (Value)
        • 5.2.1.1. OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate)
        • 5.2.1.2. Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)
      • 5.2.2. Global Athlete's Foot Drugs by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacy
        • 5.2.2.2. Retail Pharmacy
        • 5.2.2.3. Online Pharmacy
      • 5.2.3. Global Athlete's Foot Drugs by: End-user (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Athlete's Foot Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Athlete's Foot Drugs (Volume)
      • 5.3.1. Global Athlete's Foot Drugs by: Type (Volume)
        • 5.3.1.1. OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate)
        • 5.3.1.2. Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)
      • 5.3.2. Global Athlete's Foot Drugs by: Distribution Channel (Volume)
        • 5.3.2.1. Hospital Pharmacy
        • 5.3.2.2. Retail Pharmacy
        • 5.3.2.3. Online Pharmacy
      • 5.3.3. Global Athlete's Foot Drugs by: End-user (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Others
      • 5.3.4. Global Athlete's Foot Drugs Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Athlete's Foot Drugs (Price)
      • 5.4.1. Global Athlete's Foot Drugs by: Type (Price)
  • 6. Athlete's Foot Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mylan N.V. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis International AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co., Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sanofi S.A. (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bayer AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Enzon Pharmaceuticals, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Abbott Laboratories (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Athlete's Foot Drugs Sale, by Type, Distribution Channel, End-user and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Athlete's Foot Drugs (Value)
      • 7.2.1. Global Athlete's Foot Drugs by: Type (Value)
        • 7.2.1.1. OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate)
        • 7.2.1.2. Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)
      • 7.2.2. Global Athlete's Foot Drugs by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacy
        • 7.2.2.2. Retail Pharmacy
        • 7.2.2.3. Online Pharmacy
      • 7.2.3. Global Athlete's Foot Drugs by: End-user (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Athlete's Foot Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Athlete's Foot Drugs (Volume)
      • 7.3.1. Global Athlete's Foot Drugs by: Type (Volume)
        • 7.3.1.1. OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate)
        • 7.3.1.2. Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)
      • 7.3.2. Global Athlete's Foot Drugs by: Distribution Channel (Volume)
        • 7.3.2.1. Hospital Pharmacy
        • 7.3.2.2. Retail Pharmacy
        • 7.3.2.3. Online Pharmacy
      • 7.3.3. Global Athlete's Foot Drugs by: End-user (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Others
      • 7.3.4. Global Athlete's Foot Drugs Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Athlete's Foot Drugs (Price)
      • 7.4.1. Global Athlete's Foot Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Athlete's Foot Drugs: by Type(USD Million)
  • Table 2. Athlete's Foot Drugs OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate) , by Region USD Million (2015-2020)
  • Table 3. Athlete's Foot Drugs Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics) , by Region USD Million (2015-2020)
  • Table 4. Athlete's Foot Drugs: by Distribution Channel(USD Million)
  • Table 5. Athlete's Foot Drugs Hospital Pharmacy , by Region USD Million (2015-2020)
  • Table 6. Athlete's Foot Drugs Retail Pharmacy , by Region USD Million (2015-2020)
  • Table 7. Athlete's Foot Drugs Online Pharmacy , by Region USD Million (2015-2020)
  • Table 8. Athlete's Foot Drugs: by End-user(USD Million)
  • Table 9. Athlete's Foot Drugs Hospitals , by Region USD Million (2015-2020)
  • Table 10. Athlete's Foot Drugs Clinics , by Region USD Million (2015-2020)
  • Table 11. Athlete's Foot Drugs Others , by Region USD Million (2015-2020)
  • Table 12. South America Athlete's Foot Drugs, by Country USD Million (2015-2020)
  • Table 13. South America Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 14. South America Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 15. South America Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 16. Brazil Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 17. Brazil Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 18. Brazil Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 19. Argentina Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 20. Argentina Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 21. Argentina Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 22. Rest of South America Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 24. Rest of South America Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 25. Asia Pacific Athlete's Foot Drugs, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 28. Asia Pacific Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 29. China Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 30. China Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 31. China Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 32. Japan Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 33. Japan Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 34. Japan Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 35. India Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 36. India Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 37. India Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 38. South Korea Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 39. South Korea Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 40. South Korea Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 41. Taiwan Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 42. Taiwan Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 43. Taiwan Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 44. Australia Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 45. Australia Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 46. Australia Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 50. Europe Athlete's Foot Drugs, by Country USD Million (2015-2020)
  • Table 51. Europe Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 52. Europe Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 53. Europe Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 54. Germany Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 55. Germany Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 56. Germany Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 57. France Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 58. France Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 59. France Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 60. Italy Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 61. Italy Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 62. Italy Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 63. United Kingdom Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 65. United Kingdom Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 66. Netherlands Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 67. Netherlands Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 68. Netherlands Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 69. Rest of Europe Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 71. Rest of Europe Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 72. MEA Athlete's Foot Drugs, by Country USD Million (2015-2020)
  • Table 73. MEA Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 74. MEA Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 75. MEA Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 76. Middle East Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 77. Middle East Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 78. Middle East Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 79. Africa Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 80. Africa Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 81. Africa Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 82. North America Athlete's Foot Drugs, by Country USD Million (2015-2020)
  • Table 83. North America Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 84. North America Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 85. North America Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 86. United States Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 87. United States Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 88. United States Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 89. Canada Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 90. Canada Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 91. Canada Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 92. Mexico Athlete's Foot Drugs, by Type USD Million (2015-2020)
  • Table 93. Mexico Athlete's Foot Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 94. Mexico Athlete's Foot Drugs, by End-user USD Million (2015-2020)
  • Table 95. Athlete's Foot Drugs Sales: by Type(K Units)
  • Table 96. Athlete's Foot Drugs Sales OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate) , by Region K Units (2015-2020)
  • Table 97. Athlete's Foot Drugs Sales Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics) , by Region K Units (2015-2020)
  • Table 98. Athlete's Foot Drugs Sales: by Distribution Channel(K Units)
  • Table 99. Athlete's Foot Drugs Sales Hospital Pharmacy , by Region K Units (2015-2020)
  • Table 100. Athlete's Foot Drugs Sales Retail Pharmacy , by Region K Units (2015-2020)
  • Table 101. Athlete's Foot Drugs Sales Online Pharmacy , by Region K Units (2015-2020)
  • Table 102. Athlete's Foot Drugs Sales: by End-user(K Units)
  • Table 103. Athlete's Foot Drugs Sales Hospitals , by Region K Units (2015-2020)
  • Table 104. Athlete's Foot Drugs Sales Clinics , by Region K Units (2015-2020)
  • Table 105. Athlete's Foot Drugs Sales Others , by Region K Units (2015-2020)
  • Table 106. South America Athlete's Foot Drugs Sales, by Country K Units (2015-2020)
  • Table 107. South America Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 108. South America Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 109. South America Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 110. Brazil Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 111. Brazil Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 112. Brazil Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 113. Argentina Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 114. Argentina Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 115. Argentina Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 116. Rest of South America Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 117. Rest of South America Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 118. Rest of South America Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 119. Asia Pacific Athlete's Foot Drugs Sales, by Country K Units (2015-2020)
  • Table 120. Asia Pacific Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 121. Asia Pacific Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 122. Asia Pacific Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 123. China Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 124. China Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 125. China Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 126. Japan Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 127. Japan Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 128. Japan Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 129. India Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 130. India Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 131. India Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 132. South Korea Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 133. South Korea Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 134. South Korea Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 135. Taiwan Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 136. Taiwan Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 137. Taiwan Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 138. Australia Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 139. Australia Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 140. Australia Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 141. Rest of Asia-Pacific Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 142. Rest of Asia-Pacific Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 143. Rest of Asia-Pacific Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 144. Europe Athlete's Foot Drugs Sales, by Country K Units (2015-2020)
  • Table 145. Europe Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 146. Europe Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 147. Europe Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 148. Germany Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 149. Germany Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 150. Germany Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 151. France Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 152. France Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 153. France Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 154. Italy Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 155. Italy Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 156. Italy Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 157. United Kingdom Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 158. United Kingdom Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 159. United Kingdom Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 160. Netherlands Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 161. Netherlands Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 162. Netherlands Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 163. Rest of Europe Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 164. Rest of Europe Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 165. Rest of Europe Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 166. MEA Athlete's Foot Drugs Sales, by Country K Units (2015-2020)
  • Table 167. MEA Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 168. MEA Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 169. MEA Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 170. Middle East Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 171. Middle East Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 172. Middle East Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 173. Africa Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 174. Africa Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 175. Africa Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 176. North America Athlete's Foot Drugs Sales, by Country K Units (2015-2020)
  • Table 177. North America Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 178. North America Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 179. North America Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 180. United States Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 181. United States Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 182. United States Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 183. Canada Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 184. Canada Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 185. Canada Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 186. Mexico Athlete's Foot Drugs Sales, by Type K Units (2015-2020)
  • Table 187. Mexico Athlete's Foot Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 188. Mexico Athlete's Foot Drugs Sales, by End-user K Units (2015-2020)
  • Table 189. Athlete's Foot Drugs: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Athlete's Foot Drugs: by Type(USD Million)
  • Table 201. Athlete's Foot Drugs OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate) , by Region USD Million (2021-2026)
  • Table 202. Athlete's Foot Drugs Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics) , by Region USD Million (2021-2026)
  • Table 203. Athlete's Foot Drugs: by Distribution Channel(USD Million)
  • Table 204. Athlete's Foot Drugs Hospital Pharmacy , by Region USD Million (2021-2026)
  • Table 205. Athlete's Foot Drugs Retail Pharmacy , by Region USD Million (2021-2026)
  • Table 206. Athlete's Foot Drugs Online Pharmacy , by Region USD Million (2021-2026)
  • Table 207. Athlete's Foot Drugs: by End-user(USD Million)
  • Table 208. Athlete's Foot Drugs Hospitals , by Region USD Million (2021-2026)
  • Table 209. Athlete's Foot Drugs Clinics , by Region USD Million (2021-2026)
  • Table 210. Athlete's Foot Drugs Others , by Region USD Million (2021-2026)
  • Table 211. South America Athlete's Foot Drugs, by Country USD Million (2021-2026)
  • Table 212. South America Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 213. South America Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 214. South America Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 215. Brazil Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 216. Brazil Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 217. Brazil Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 218. Argentina Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 219. Argentina Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 220. Argentina Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 221. Rest of South America Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 222. Rest of South America Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 223. Rest of South America Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 224. Asia Pacific Athlete's Foot Drugs, by Country USD Million (2021-2026)
  • Table 225. Asia Pacific Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 226. Asia Pacific Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 227. Asia Pacific Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 228. China Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 229. China Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 230. China Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 231. Japan Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 232. Japan Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 233. Japan Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 234. India Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 235. India Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 236. India Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 237. South Korea Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 238. South Korea Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 239. South Korea Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 240. Taiwan Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 241. Taiwan Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 242. Taiwan Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 243. Australia Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 244. Australia Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 245. Australia Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 246. Rest of Asia-Pacific Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 247. Rest of Asia-Pacific Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 248. Rest of Asia-Pacific Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 249. Europe Athlete's Foot Drugs, by Country USD Million (2021-2026)
  • Table 250. Europe Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 251. Europe Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 252. Europe Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 253. Germany Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 254. Germany Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 255. Germany Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 256. France Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 257. France Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 258. France Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 259. Italy Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 260. Italy Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 261. Italy Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 262. United Kingdom Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 263. United Kingdom Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 264. United Kingdom Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 265. Netherlands Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 266. Netherlands Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 267. Netherlands Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 268. Rest of Europe Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 269. Rest of Europe Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 270. Rest of Europe Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 271. MEA Athlete's Foot Drugs, by Country USD Million (2021-2026)
  • Table 272. MEA Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 273. MEA Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 274. MEA Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 275. Middle East Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 276. Middle East Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 277. Middle East Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 278. Africa Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 279. Africa Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 280. Africa Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 281. North America Athlete's Foot Drugs, by Country USD Million (2021-2026)
  • Table 282. North America Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 283. North America Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 284. North America Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 285. United States Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 286. United States Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 287. United States Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 288. Canada Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 289. Canada Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 290. Canada Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 291. Mexico Athlete's Foot Drugs, by Type USD Million (2021-2026)
  • Table 292. Mexico Athlete's Foot Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 293. Mexico Athlete's Foot Drugs, by End-user USD Million (2021-2026)
  • Table 294. Athlete's Foot Drugs Sales: by Type(K Units)
  • Table 295. Athlete's Foot Drugs Sales OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate) , by Region K Units (2021-2026)
  • Table 296. Athlete's Foot Drugs Sales Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics) , by Region K Units (2021-2026)
  • Table 297. Athlete's Foot Drugs Sales: by Distribution Channel(K Units)
  • Table 298. Athlete's Foot Drugs Sales Hospital Pharmacy , by Region K Units (2021-2026)
  • Table 299. Athlete's Foot Drugs Sales Retail Pharmacy , by Region K Units (2021-2026)
  • Table 300. Athlete's Foot Drugs Sales Online Pharmacy , by Region K Units (2021-2026)
  • Table 301. Athlete's Foot Drugs Sales: by End-user(K Units)
  • Table 302. Athlete's Foot Drugs Sales Hospitals , by Region K Units (2021-2026)
  • Table 303. Athlete's Foot Drugs Sales Clinics , by Region K Units (2021-2026)
  • Table 304. Athlete's Foot Drugs Sales Others , by Region K Units (2021-2026)
  • Table 305. South America Athlete's Foot Drugs Sales, by Country K Units (2021-2026)
  • Table 306. South America Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 307. South America Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 308. South America Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 309. Brazil Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 310. Brazil Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 311. Brazil Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 312. Argentina Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 313. Argentina Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 314. Argentina Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 315. Rest of South America Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 316. Rest of South America Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 317. Rest of South America Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 318. Asia Pacific Athlete's Foot Drugs Sales, by Country K Units (2021-2026)
  • Table 319. Asia Pacific Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 320. Asia Pacific Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 321. Asia Pacific Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 322. China Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 323. China Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 324. China Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 325. Japan Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 326. Japan Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 327. Japan Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 328. India Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 329. India Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 330. India Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 331. South Korea Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 332. South Korea Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 333. South Korea Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 334. Taiwan Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 335. Taiwan Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 336. Taiwan Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 337. Australia Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 338. Australia Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 339. Australia Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 340. Rest of Asia-Pacific Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 341. Rest of Asia-Pacific Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 342. Rest of Asia-Pacific Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 343. Europe Athlete's Foot Drugs Sales, by Country K Units (2021-2026)
  • Table 344. Europe Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 345. Europe Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 346. Europe Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 347. Germany Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 348. Germany Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 349. Germany Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 350. France Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 351. France Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 352. France Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 353. Italy Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 354. Italy Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 355. Italy Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 356. United Kingdom Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 357. United Kingdom Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 358. United Kingdom Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 359. Netherlands Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 360. Netherlands Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 361. Netherlands Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 362. Rest of Europe Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 363. Rest of Europe Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 364. Rest of Europe Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 365. MEA Athlete's Foot Drugs Sales, by Country K Units (2021-2026)
  • Table 366. MEA Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 367. MEA Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 368. MEA Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 369. Middle East Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 370. Middle East Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 371. Middle East Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 372. Africa Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 373. Africa Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 374. Africa Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 375. North America Athlete's Foot Drugs Sales, by Country K Units (2021-2026)
  • Table 376. North America Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 377. North America Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 378. North America Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 379. United States Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 380. United States Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 381. United States Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 382. Canada Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 383. Canada Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 384. Canada Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 385. Mexico Athlete's Foot Drugs Sales, by Type K Units (2021-2026)
  • Table 386. Mexico Athlete's Foot Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 387. Mexico Athlete's Foot Drugs Sales, by End-user K Units (2021-2026)
  • Table 388. Athlete's Foot Drugs: by Type(USD/Units)
  • Table 389. Research Programs/Design for This Report
  • Table 390. Key Data Information from Secondary Sources
  • Table 391. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Athlete's Foot Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Athlete's Foot Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 6. Global Athlete's Foot Drugs: by End-user USD Million (2015-2020)
  • Figure 7. South America Athlete's Foot Drugs Share (%), by Country
  • Figure 8. Asia Pacific Athlete's Foot Drugs Share (%), by Country
  • Figure 9. Europe Athlete's Foot Drugs Share (%), by Country
  • Figure 10. MEA Athlete's Foot Drugs Share (%), by Country
  • Figure 11. North America Athlete's Foot Drugs Share (%), by Country
  • Figure 12. Global Athlete's Foot Drugs: by Type K Units (2015-2020)
  • Figure 13. Global Athlete's Foot Drugs: by Distribution Channel K Units (2015-2020)
  • Figure 14. Global Athlete's Foot Drugs: by End-user K Units (2015-2020)
  • Figure 15. South America Athlete's Foot Drugs Share (%), by Country
  • Figure 16. Asia Pacific Athlete's Foot Drugs Share (%), by Country
  • Figure 17. Europe Athlete's Foot Drugs Share (%), by Country
  • Figure 18. MEA Athlete's Foot Drugs Share (%), by Country
  • Figure 19. North America Athlete's Foot Drugs Share (%), by Country
  • Figure 20. Global Athlete's Foot Drugs: by Type USD/Units (2015-2020)
  • Figure 21. Global Athlete's Foot Drugs share by Players 2020 (%)
  • Figure 22. Global Athlete's Foot Drugs share by Players (Top 3) 2020(%)
  • Figure 23. Global Athlete's Foot Drugs share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Mylan N.V. (United States) Revenue: by Geography 2020
  • Figure 27. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Novartis International AG (Switzerland) Revenue: by Geography 2020
  • Figure 29. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 34. Sanofi S.A. (France) Revenue: by Geography 2020
  • Figure 35. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 37. Enzon Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Enzon Pharmaceuticals, Inc. (United States) Revenue: by Geography 2020
  • Figure 39. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 40. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 41. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 42. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 43. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 44. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 45. Global Athlete's Foot Drugs: by Type USD Million (2021-2026)
  • Figure 46. Global Athlete's Foot Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 47. Global Athlete's Foot Drugs: by End-user USD Million (2021-2026)
  • Figure 48. South America Athlete's Foot Drugs Share (%), by Country
  • Figure 49. Asia Pacific Athlete's Foot Drugs Share (%), by Country
  • Figure 50. Europe Athlete's Foot Drugs Share (%), by Country
  • Figure 51. MEA Athlete's Foot Drugs Share (%), by Country
  • Figure 52. North America Athlete's Foot Drugs Share (%), by Country
  • Figure 53. Global Athlete's Foot Drugs: by Type K Units (2021-2026)
  • Figure 54. Global Athlete's Foot Drugs: by Distribution Channel K Units (2021-2026)
  • Figure 55. Global Athlete's Foot Drugs: by End-user K Units (2021-2026)
  • Figure 56. South America Athlete's Foot Drugs Share (%), by Country
  • Figure 57. Asia Pacific Athlete's Foot Drugs Share (%), by Country
  • Figure 58. Europe Athlete's Foot Drugs Share (%), by Country
  • Figure 59. MEA Athlete's Foot Drugs Share (%), by Country
  • Figure 60. North America Athlete's Foot Drugs Share (%), by Country
  • Figure 61. Global Athlete's Foot Drugs: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Mylan N.V. (United States)
  • Novartis International AG (Switzerland)
  • Pfizer Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Sanofi S.A. (France)
  • Bayer AG (Germany)
  • Enzon Pharmaceuticals, Inc. (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Abbott Laboratories (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation